MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell and gene therapies. Their core ExPERT ATx, sTX, GTx, and VLx tools use ...
A vascularized organoid model of hormone-secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies. “Our results highlight the importance ...
Deadlifts hit a plateau? Shoulders hunching forward as you run? Or maybe you've just found yourself slumped over your desk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback